Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
39.75 -0.91 (-2.24%) 08/31/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 39.75 unch (unch) -
Quote Overview for Thu, Aug 31st, 2023
Day Low
39.51
Day High
41.00
Open 40.62
Previous Close 40.66 40.66
Volume 31,368,500 31,368,500
Avg Vol 3,309,755 3,309,755
Stochastic %K 66.94% 66.94%
Weighted Alpha -10.40 -10.40
5-Day Change +1.63 (+4.28%) +1.63 (+4.28%)
52-Week Range 35.17 - 49.53 35.17 - 49.53
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,084,848
  • Shares Outstanding, K 52,449
  • Annual Sales, $ 1,202 M
  • Annual Income, $ 40,410 K
  • EBIT $ 109 M
  • EBITDA $ 264 M
  • 60-Month Beta 1.07
  • Price/Sales 1.77
  • Price/Cash Flow 8.01
  • Price/Book 2.34
  • Price/Earnings ttm 20.33
  • Earnings Per Share ttm 2.00
  • Most Recent Earnings $0.56 on 08/02/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 0.54
  • Number of Estimates 7
  • High Estimate 0.76
  • Low Estimate 0.48
  • Prior Year 0.54
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.93 +4.80%
on 08/25/23
Period Open: 41.21
41.73 -4.74%
on 08/01/23
-1.46 (-3.54%)
since 07/31/23
3-Month
37.90 +4.88%
on 06/01/23
Period Open: 38.16
44.12 -9.90%
on 07/19/23
+1.59 (+4.17%)
since 05/31/23
52-Week
35.17 +13.02%
on 11/17/22
Period Open: 43.58
49.53 -19.75%
on 02/09/23
-3.83 (-8.79%)
since 08/26/22

Most Recent Stories

More News
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive: Q2 Earnings Snapshot

NuVasive: Q2 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces Second Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive: Q1 Earnings Snapshot

NuVasive: Q1 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces First Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Shareholders Approve Merger Agreement with Globus Medical

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
GMED : 73.39 (+0.26%)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INFI : 0.0080 (-50.00%)
ANGN : 1.0000 (+2.04%)
NUVA : 39.75 (-2.24%)
SUMO : 12.04 (-0.08%)
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
GMED : 73.39 (+0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NuVasive, Inc. is one of the leading global medical device companies in the global spine market, focused on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The principal product offering includes a minimally-disruptive surgical platform called Maximum...

See More

Key Turning Points

3rd Resistance Point 42.15
2nd Resistance Point 41.58
1st Resistance Point 40.66
Last Price 39.75
1st Support Level 39.17
2nd Support Level 38.60
3rd Support Level 37.68

See More

52-Week High 49.53
Fibonacci 61.8% 44.04
Fibonacci 50% 42.35
Fibonacci 38.2% 40.66
Last Price 39.75
52-Week Low 35.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies